The roles of tumor necrosis factor-α, interleukin-1 and interleukin-12 in murine cytomegalovirus infection

Immunology

Volumn 91, Issue 1, 1997, Pages 45-52

  Yerkovich, S T ^a   Olver, S D ^a   Lenzo, J C ^a   Peacock, C D ^a   Price, P ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; BETAHERPESVIRINAE; C57BL MOUSE; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DISEASE PREDISPOSITION; GERMFREE ANIMAL; IMMUNOLOGY; LIVER; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; FEMALE; INTERLEUKIN-1; INTERLEUKIN-12; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0030612172     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00226.x     Document Type: Article

References (52)

1. GRIFFITHS P.D. & GRUNDY J.E (1987) Molecular biology and immunology of cytomegalovirus. Biochem J 241, 313.
2. GRIFFITHS P.D. & GRUNDY J.E. (1988) The status of CMV as a human pathogen. Epidem Inf 100, 1.
3. MELNICK J.L., ADAM E. & DEBAKEY M.E. (1990) Possible role of cytomegalovirus in atherogenesis. J Am Med Assoc 263, 2204.
4. KLEMOLA E., KAARIAINEN L., VON ESSEN R., HALTIA K., KOIVUNIEMI A. & VON BONSDORFF C.H. (1967) Further studies on cytomegalovirus mononucleosis in previously healthy individuals. Acta Med Scand 182, 311.
5. SHUSTERMAN N.H., FRAUENHOFFER C. & KINSEY M.D. (1978) Fatal massive hepatic necrosis in cytomegalovirus mononucleosis. Ann Int Med 88, 810.
6. SNOVER D.C. & HORWITZ C.A. (1984) Liver disease in cytomegalovirus mononucleosis: a light microscopical and immunoperoxidase study of six cases. Hepatology 4, 408.
7. GRUNDY (CHALMER) J.E., MACKENZIE J.S. & STANLEY N.F. (1981) Infection of H-2 and Non-H-2 genes on the resistance to murine cytomegalovirus infection. Infect Immunol 32, 277.
8. PRICE P., GIBBONS A.E. & SHELLAM G.R. (1990) H-2 class I loci determine sensitivity to murine cytomegalovirus in macrophages and fibroblasts. Immunogenetics 32, 20.
9. PRICE P., OLVER S.D., GIBBONS A.E., TEO H.K. & SHELLAM G.R. (1992) Characterization of thymic involution induced by murine cytomegalovirus infection. Immunol Cell Biol. 71, 155.
10. OLVER S.D., PRICE P. & SHELLAM G.R. (1994) Cytomegalovirus hepatitis: characterization of the inflammatory infiltrate in resistant and susceptible mice. Clin ExpImmunol 98, 375.
11. PRICE P., EDDY K.S., PAPADIMITRIOU J.M., FAULKNER D.L. & SHELLAM G.R. (1991) Genetic determination of cytomegalovirus-induced and age-related cardiopathy in inbred mice: characterization of infiltrating cells. Am J Pathol 138, 59.
12. SCALZO A.A., FITZGERALD N.A., WALLACE C.R. et al. (1992) The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149, 581.
13. PAVIC I., POLIC B., CINKOVIC I., LUCIN P., JONJIC S. & KOSZINOWSKI U.H. (1993) Participation of endogenous tumour necrosis factor-α in host resistance to cytomegalovirus infection. J Gen Virol 74, 2215.
14. SHANLEY J.D., GOFF E., DEBS R.J. & FORMAN S.J. (1994) The role of tumour necrosis factor-α in acute murine cytomegalovirus infection in BALB/c mice. J Inf Dis 169, 1088.
15. ANDERSON K.P., LIE Y.S., LOW M.A.L. & FENNIE E.H. (1993) Effects of tumour necrosis factor-α treatment on mortality in murine cytomegalovirus infected mice. Antiviral Res 21, 343.
16. NEUMANN D.A., LANE J.R., ALLEN G.S., HERSKOWITZ A. & ROSE N.R. (1993) Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis? Clin Imm Immunopathol 68, 181.
17. LANE J.R., NEUMANN D.A., LATAND-WALKER A., HERSKOWITZ A. & ROSE N.R. (1993) Role of IL-1 and tumour necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 151, 1682.
18. WATANABE Y., MORITA M., IKEMATSU N. & AKAIKE T. (1995) Tumour necrosis factor-α and interleukin-1β but not interferon-γ induce vascular cell adhesion molecule-1 expression on primary cultured murine hepatocytes. Biochem Biophys Res Commun 209, 335.
19. MORRIS S.C., MADDEN K.B., ADAMOVICZ J.J. et al. (1994) Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 152, 1047.
20. ORANGE J.S., WANG B., TERHORST C. & BIRON C.A. (1995) Requirement for natural killer cell-produced interferon-γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182, 1045.
21. FANSLOW W.C., SIMS J.E., SASSENFELD H. et al. (1990) Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor. Science 248, 739.
22. MOHLER K.M., TORRANCE D.S., SMITH C.A. et al. (1993) Soluble tumour necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151, 1548.
23. BURSTEN S., WEEKS R., WEST J. et al. (1994) Potential role for phosphatidic acid in mediating the inflammatory responses to TNF-α and IL-1β. Circulatory Shock 44, 14.
24. PRICE P., OLVER S.D., GIBBONS A.E. & SHELLAM G.R. (1993) B-cell activation following murine cytomegalovirus infection: implications for autoimmunity. Immunology 78, 14.
25. SCALZO A.A., FITZGERALD N.A., SIMMONS A., LA VISTA A.B. & SHELLAM G.R. (1990) Cmv-1, A genetic locus thai controls murine cytomegalovirus replication in the spleen. J Exp Med 171, 1469.
26. HOPKINS S.J. & HUMPHREYS M (1989) Simple, sensitive and specific bioassay of interleukin-1 Immunol Methods 120, 271.
27. DENTENER M.A., GREVE J.W., MAESSEN J.G. & BUURMAN W.A. (1989) Role of tumour necrosis factor in the phenomenon of the enhanced sensitivity of animals to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol 11, 321.
28. VAN BRUGGEN I., PRICE P., ROBERTSON T.A. & PAPADIMITRIOU J.M. (1989) Morphological and functional changes during cytomegalovirus replication in murine macrophages. J Leuk Biol 46, 508.
29. BEUTLER B.A., MILSARK I.W. & CERAMI A. (1985) Cachectin/ tumour necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 135, 3972.
30. DINARELLO C.A. ( 1988) Interleukin-1 Ann NY Acad Sci 546, 122.
31. PRICE P., WINTER J.G. & SHELLAM G.R. (1987) Genetically determined resistance to murine cytomegalovirus: a role for lymphocytostatic macrophages. J Gen Virol 68, 2997.
32. ALLCOCK R.J.N., PEACOCK C.D. & PRICE P. (1996) The inflammatory macrophage response to murine cytomegalovirus in mice with a retroviral immunodeficiency syndrome (MAIDS). J Leuk Biol 60, 44.
33. PRICE P., WINTER J.G. & SHELLAM G.R. (1989) The inflammatory macrophage response to murine cytomegalovirus in genetically susceptible mice. Arch Virol 106, 35.
34. SMITH P.D., SAINI S.S., RAFFELD M., MANISCHEWITZ J.F. & WAHL S.M. (1992) Cytomegalovirus induction of tumour necrosis factor-α by the monocytes and mucosal macrophages. J Clin Invest 90, 1642.
35. MOSES A.V. & GARNETT H.M. (1990) The effect of human cytomegalovirus on the production and biologic action of interleukin-1. Inf Dis 162, 381.
36. HAAGMANS B.L., VAN DER EERTWEGH A.J.M., CLAASSEN E., HORZINEK M.C. & SCHIJNS V.E.C.J. (1994) Tumour necrosis factor-α production during cytomegalovirus infection in immunosuppressed rats. J Gen Virol 75, 779.
37. TILG H., VOGEL W., HEROLD M., AULITZKY W.E. & HUBER C. (1991) Cachexia and tumour necrosis factor alpha in cytomegalovirus infection. J Clin Pathol. 44, 519.
38. ASHKENAZI A, MARSTERS S.A., CAPON D.J. et al. (1991) Protection against endotoxic shock by a tumour necrosis factor receptor immunoadhesion. Proc Natl Acad Sci USA 88, 10 535.
39. MANETTI R., PARRONCHI P., GUIDIZI M.G., MAGGI E., TRINCHIERI G. & ROMAGNANI S. (1993) Natural killer cell stimulatory factor (interleukin-12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 177, 1199.
40. STEVENS T.L., BOSSIE A., SANDERS V.M. et al. (1988) Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334, 255.
41. MESTAN J., DIGEL W., MITTNACHT S. et al. (1986) Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323, 816.
42. WONG G.H.W. & GOEDDEL D. (1986) Tumour necrosis factor-α and β inhibit virus replication and synergize with interferons. Nature 323, 819.
43. HAAGMANS B.L., STALS F.S., VAN DER MEIDE P.H., BRUGGEMAN C.A., HORZINEK M.C. & SCHIJNS V.E.C.J. (1994) Tumour necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J Virol 68, 2297.
44. FISHER C.J., AGOSTI J.M., OPAL S.M. et al. (1996) Treatment of septic shock with the tumour necrosis factor receptor: Fc fusion protein. N Engl J Med. 334, 1697.
45. RICE G.C., BROWN P.A., NELSON R.J., BIANCO J.A., SINGER J.W. & BURSTEN S. (1994) Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci USA 91, 3857.
46. ZUCKERMAN S.H., SHELLHAAS J. & BUTLER L.D. (1989) Differential regulation of lipopolysaccharide induced IL-1 and TNF synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19, 301.
47. PRICE P., OLVER S.D., SILICH M., NADOR T.Z., YERKOVICH S.T. & WILSON S.G. (1996) Adrenalitis and the adrenocortical response of resistant and susceptible mice to acute murine cytomegalovirus infection. Eur J Clin Invest 26, 811.
48. ORANGE J.S. & BIRON C.A. (1996) An absolute and restricted requirement for IL-12 in natural killer cell IFNγ production and antiviral defense. J Immunol. 156, 1138.
49. WELSH R.M., TAY C.H., VARGA S.M., O'DONELL C.L., VERGILIS K.L. & SELIN L.K. (1996) Lymphocyte-dependant "natural" immunity to virus infections mediated by both natural killer cells and memory T cells. Sem Virol. 7, 95.
50. TRIPP C.S., WOLFE S.F. & UNANUE E.R. (1993) Interleukin-12 and tumour necrosis factor-α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis and interleukin-10 is a physiological antagonist. Proc Natl Acad Sci USA 90, 3725.
51. LUCIN P., JONJIC S., MESSERLE M., POLIC B., HENGEL K. & KOSZINOWSKI U.H. (1994) Late phase inhibition of MCMV replication by synergistic action of IFNγ and tumour necrosis factor. J Gen Virol. 75, 101.
52. LATHBURY L.J., ALLAN J.E., SHELLAM G.R. & SCALZO A.A. (1996) Effect of host genotype in determining the relative roles of NK cells and T cells in mediating protection against murine cytomegalovirus infection. J Gen Virol 77, 2605.